To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Floseal hemostatic agent reduces blood loss but not transfusion needs in TKA patients

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
December 2014

Floseal hemostatic agent reduces blood loss but not transfusion needs in TKA patients

Vol: 3| Issue: 12| Number:18| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Prospective, Randomized Trial to Evaluate Efficacy of a Thrombin-Based Hemostatic Agent in Total Knee Arthroplasty

J Arthroplasty. 2014 Oct;29(10):1950-5.

Contributing Authors:
JC Suarez EM Slotkin AM Alvarez CR Szubski WK Barsoum PD Patel

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

108 patients undergoing unilateral primary total knee arthroplasty were randomly allocated to either receive a thrombin-based topical hemostatic matrix or to a control group who did not receive the hemostatic agent. The study sought to determine the effects of the hemostatic sealant on inblood loss, as well as the need for transfusion. Results revealed the mean blood loss, drain output and length ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.